adriamycinol has been researched along with Cardiomyopathies, Primary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Andrade, JM; Lanchote, VL; Oliveira, ML; Pippa, LF; Rocha, A | 1 |
| Atkinson, JB; Boucek, RJ; Buck, S; Cusack, BJ; Dodd, DA; Fleischer, S; Olson, RD | 1 |
2 other study(ies) available for adriamycinol and Cardiomyopathies, Primary
| Article | Year |
|---|---|
Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: Estimation of doxorubicin hepatic extraction ratio.
Topics: Adult; Antineoplastic Agents; Area Under Curve; Biological Variation, Population; Breast Neoplasms; Cardiomyopathies; Chemotherapy, Adjuvant; Chromatography, High Pressure Liquid; Doxorubicin; Female; Hepatobiliary Elimination; Humans; Kidney; Liver; Mastectomy; Middle Aged; Neoadjuvant Therapy; Renal Elimination; Tandem Mass Spectrometry | 2020 |
Doxorubicin cardiomyopathy is associated with a decrease in calcium release channel of the sarcoplasmic reticulum in a chronic rabbit model.
Topics: Animals; Atrial Function; Calcium Channels; Calcium-Transporting ATPases; Cardiomyopathies; Doxorubicin; Heart Atria; Muscle, Smooth; Myocardial Contraction; Rabbits; Ryanodine; Sarcoplasmic Reticulum | 1993 |